Impact of Brokerage Rating on The Advisory Board Company(ABCO)

Many The Advisory Board Company(ABCO) Stock Research Financial Advisors from Investment Banking firms have advised their client and investors on the stock. Company shares were Reiterated by Stifel on Jan 31, 2017 to Hold, Raises Price Target to $ 47 from a previous price target of $38 .The Advisory Board Company was Downgraded by Piper Jaffray to Neutral on Jan 13, 2017.

Company has reported several Insider transactions to the SEC, on Feb 8, 2017, Hoose Mary Van (Chief Talent Officer) sold 8,484 shares at 46.84 per share price.On Feb 3, 2017, Cormac F Miller (Chief Product Officer) sold 750 shares at 45.89 per share price.On Jan 11, 2017, Robert W Musslewhite (Chief Executive Officer) sold 5,500 shares at 35.76 per share price.

The Advisory Board Company Last issued its quarterly earnings results on Nov 1, 2016. The company reported $0.28 EPS for the quarter, missing the analyst consensus estimate by $ -0.12. Analyst had a consensus of $0.40. The company had revenue of $200.50 million for the quarter, compared to analysts expectations of $203.35 million. During the same quarter in the previous year, the company posted $0.33 EPS.

The Advisory Board Company (NASDAQ:ABCO) has received a short term rating of hold from experts at Zacks with a rank of 3. The stock has been rated an average of 2.19 by 16 Brokerage Firm. 7 Wall Street Firms have rated the stock as a strong buys. 8 Brokerage Firms have advised hold. A sell rating was given by 1 analyst.

The Advisory Board Company (NASDAQ:ABCO) stock has received a short term price target of $ 43.17 from 12 Analyst. The share price can be expected to fluctuate from the mean short term target, can be seen from the standard deviation reading of $6.18. The higher estimate of target price is $51 , while the lower price target estimate is $31

The Advisory Board Company (NASDAQ:ABCO) rose 0.85% or 0.4 points on Tuesday and made its way into the gainers of the day. After trading began at $46.95 the stock was seen hitting $47.6 as a peak level and $46.7 as the lowest level. The stock ended up at $47.4. The daily volume was measured at 860,456 shares. The 52-week high of the share price is $51.225 and the 52-week low is $18.87. The company has a market cap of $1,903 million.

The Advisory Board Company provides best practices research and analysis to the health care industry, focusing on business strategy, operations and general management issues. The Company provides its best practices research and analysis through discrete annual programs to a membership of more than 2,000 hospitals, health systems, pharmaceutical and biotech companies, health care insurers, and medical device companies in the United States. Each program provides members with best practices research reports, executive education and other supporting research services.


Share this post

Leave a Reply